Composition
The vaccine consists of two components with an equal number of doses:
strain BG-04 at ≥ 640 GAU per dose,
strain GBK-2 at ≥ 640 GAU per dose;
strain "MAV/RK–13/20" at ≥ 104.0 TCID50 per dose.
Pharmaceutical form
Suspension and lyophilisate.
Immunobiological properties
Vaccination protects rabbits from viral hemorrhagic disease and myxomatosis for 8-10 months, and protective antibodies are formed 7-14 days after vaccination.
Animal species
Rabbits.
Indications for use
